Literature DB >> 7609148

Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors.

N S Schenkman1, I A Sesterhenn, L Washington, Y A Tong, C M Weghorst, G S Buzard, S Srivastava, J W Moul.   

Abstract

PURPOSE: To determine if primary testicular germ cell tumors that overexpress p53 tumor suppressor gene protein have p53 gene mutations.
MATERIALS AND METHODS: We examined 30 primary testicular tissues from 26 patients representing two groups. Group one consisted of eleven cases (6 nonseminomatous germ cell tumors and 5 seminomas) in which tissue samples for DNA analysis were microdissected from paraffin block regions with elevated immunohistochemical staining for p53 protein. Group two consisted of 19 testis tumor tissues which had been fresh frozen and were chosen to correspond to archival tissue specimens exhibiting elevated levels of p53 protein. The DNA was extracted from these tissues and subjected to exon specific amplification by polymerase chain reaction (PCR) and cold single-strand conformation polymorphism (Cold SSCP) analysis.
RESULTS: In these cases with elevated p53 protein, no p53 gene exon 5-8 mutations were detected except 1 seminoma with a codon 140 silent mutation (no protein alteration).
CONCLUSIONS: Testicular tumors appear to exhibit elevated levels of wild-type p53 protein, the significance of which is yet to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609148     DOI: 10.1097/00005392-199508000-00081

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors.

Authors:  Baozong Li; Qian Cheng; Zhenyu Li; Jiandong Chen
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

2.  A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13.

Authors:  A J Muller; A K Teresky; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Germ cell tumors of the testis overexpress wild-type p53.

Authors:  L Guillou; A Estreicher; P Chaubert; J Hurlimann; A M Kurt; G Metthez; R Iggo; A C Gray; P Jichlinski; H J Leisinger; J Benhattar
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 4.  Testicular cancer from diagnosis to epigenetic factors.

Authors:  Mariarosaria Boccellino; Daniela Vanacore; Silvia Zappavigna; Carla Cavaliere; Sabrina Rossetti; Carmine D'Aniello; Paolo Chieffi; Evzen Amler; Carlo Buonerba; Giuseppe Di Lorenzo; Rossella Di Franco; Alessandro Izzo; Raffaele Piscitelli; Gelsomina Iovane; Paolo Muto; Gerardo Botti; Sisto Perdonà; Michele Caraglia; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-09-18

Review 5.  Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.

Authors:  Dennis M Timmerman; Tessa L Remmers; Sanne Hillenius; Leendert H J Looijenga
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 6.  Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.

Authors:  Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

Review 7.  Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.

Authors:  Francesco Jacopo Romano; Sabrina Rossetti; Vincenza Conteduca; Giuseppe Schepisi; Carla Cavaliere; Rossella Di Franco; Elvira La Mantia; Luigi Castaldo; Flavia Nocerino; Gianluca Ametrano; Francesca Cappuccio; Gabriella Malzone; Micaela Montanari; Daniela Vanacore; Vincenzo Quagliariello; Raffaele Piscitelli; Maria Filomena Pepe; Massimiliano Berretta; Carmine D'Aniello; Sisto Perdonà; Paolo Muto; Gerardo Botti; Gennaro Ciliberto; Bianca Maria Veneziani; Francesco De Falco; Piera Maiolino; Michele Caraglia; Maurizio Montella; Ugo De Giorgi; Gaetano Facchini
Journal:  Oncotarget       Date:  2016-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.